New Immunization Cancer Research

In the long course of tumor research, immune research has made great progress in the fight against cancer, thanks to a deep understanding of how tumors escape the natural immune response. Next-generation sequencing (NGS) is a new method and method based on tumor immune research that can study therapeutic response factors. NGS's study of the mechanisms used by tumors to evade immune responses has led to promising therapeutic targets. These therapies enhance the ability of the immune system to target cancer or limit the ability of tumors to evade the immune response. In addition, NGS can help determine which pathways are activated in the tumor environment and participate in processes such as cancer cell proliferation, survival, invasion, and metastasis. Creative Proteomics has professional researchers who use NGS to discover biomarkers and apply genomics to personalized tumor immunotherapy. At the same time, we provide professional personalized services for you to design and provide your new type of immune tumor research.

NGS-based Immuno-Oncology Research Solution

Our Advantage

Mature and reliable Search for New Immunization Cancer Research platform: rich project experience, participate in major projects, and publish high-level cooperation results.

The analysis contents and methods based on high-quality data analysis, pre-research and verification are indeed mature and feasible.

Please contact us to find out how we can help you achieve the next research breakthrough.

Learn More

* For Research Use Only. Not for use in the treatment or diagnosis of disease.

Related Services:


  • USA
  • Tel:
  • Fax:
  • Email:
  • Germany


Copyright © 2024 Creative Proteomics. All rights reserved.